» Articles » PMID: 11152866

Molecular Biology of K(+) Channels and Their Role in Cardiac Arrhythmias

Overview
Journal Am J Med
Specialty General Medicine
Date 2001 Jan 12
PMID 11152866
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

The configuration of cardiac action potentials varies considerably from one region of the heart to another. These differences are caused by differential cellular expression of several types of K(+) channel genes. The channels encoded by these genes can be grouped into several classes depending on the stimulus that permits the channels to open and conduct potassium ions. K(+) channels are activated by changes in transmembrane voltage or binding of ligands. Voltage-gated channels are normally the most important players in determining the shape and duration of action potentials and include the delayed rectifiers and the transient outward potassium channels. Ligand-gated channels include those that probably have only minor roles in shaping repolarization under normal conditions but, when activated by extracellular acetylcholine or a decrease in the intracellular concentration of ATP, can substantially shorten action potential duration. Inward rectifier K(+) channels are unique in that they are basically stuck in the open state but can be blocked in a voltage-dependent manner by intracellular Mg(2+), Ca(2+), and polyamines. Other K(+) channels have been described that provide a small background leak conductance. Many of these cardiac K(+) channels have been cloned in the past decade, permitting detailed studies of the molecular basis of their function and facilitating the discovery of the molecular basis of several forms of congenital arrhythmias. Drugs that block cardiac K(+) channels and prolong action potential duration have been developed as antiarrhythmic agents. However, many of these same drugs, as well as other common medications that are structurally unrelated, can also cause long QT syndrome and induce ventricular arrhythmia.

Citing Articles

Identifying plant-derived antiviral alkaloids as dual inhibitors of SARS-CoV-2 main protease and spike glycoprotein through computational screening.

Yamin R, Ahmad I, Khalid H, Perveen A, Abbasi S, Nishan U Front Pharmacol. 2024; 15:1369659.

PMID: 39086396 PMC: 11288853. DOI: 10.3389/fphar.2024.1369659.


In-silico evaluation of natural alkaloids against the main protease and spike glycoprotein as potential therapeutic agents for SARS-CoV-2.

Shah M, Yamin R, Ahmad I, Wu G, Jahangir Z, Shamim A PLoS One. 2024; 19(1):e0294769.

PMID: 38175855 PMC: 10766191. DOI: 10.1371/journal.pone.0294769.


Zebrafish cardiac repolarization does not functionally depend on the expression of the hERG1b-like transcript.

Genge C, Muralidharan P, Kemp J, Hull C, Yip M, Simpson K Pflugers Arch. 2023; 476(1):87-99.

PMID: 37934265 DOI: 10.1007/s00424-023-02875-z.


Docking of T6361 Analogues as Potential Inhibitors of MurA Followed by ADME-Toxicity Study.

Boulhissa I, Boucherit H, Chikhi A, Bensegueni A Curr Drug Discov Technol. 2023; 21(3):1-8.

PMID: 37929742 DOI: 10.2174/0115701638244582231025110143.


NADPH Oxidases and Oxidative Stress in the Pathogenesis of Atrial Fibrillation.

Ramos-Mondragon R, Lozhkin A, Vendrov A, Runge M, Isom L, Madamanchi N Antioxidants (Basel). 2023; 12(10).

PMID: 37891912 PMC: 10604902. DOI: 10.3390/antiox12101833.